Research Reports on Top Stocks: Verizon, Nokia, CYS Investments, Prospect Capital, Huntington Bancshares, and Nektar Therapeutics

VANCOUVER, British Columbia, Nov. 15, 2012 /PRNewswire/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and equity research for the following companies: Verizon (NYSE: VZ), Nokia (NYSE: NOK), CYS Investments (NYSE: CYS), Prospect Capital (NASDAQ: PSEC), Huntington Bancshares (NASDAQ: HBAN), and Nektar Therapeutics (NASDAQ: NKTR).

(Logo: http://photos.prnewswire.com/prnh/20121105/HK06856LOGO )

(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)

Report Highlights:

Verizon Communications Inc. (NYSE: VZ): In the last three months, Verizon Communications Inc. (NYSE: VZ) insiders have totally made Market Option Sale for about US$1.03 million, which ranged in price from US$45.15 to US$45.48 each. In the last trading session, Verizon shares dipped US$0.30 per share (equivalent to -0.71%), where stock prices fell to US$42.24. Pennystocksinsiders.com thinks that it is a clever way to check if insiders in Verizon are starting to buy more company shares. See insider trade report for VZ here.

Read Full Report: http://www.Pennystocksinsiders.com/PR/111512A/VZ/Verizon.pdf

Nokia Corporation (ADR) (NYSE: NOK): Shares of Nokia Corporation (ADR) (NYSE: NOK) gapped open sharply higher in the last trading session. Still, the stock finally dipped US$0.02 (or -0.74%) to US$2.67. Its price, as of the latest close, was up 64% compared with the 52-week low and was 151% below the 52-week high. Investors may want to find out how Nokia insiders like CEOs, CFOs and Directors are thinking about the future of the company. Check this insider trade report for NOK here.

Read Full Report: http://www.Pennystocksinsiders.com/PR/111512A/NOK/Nokia.pdf

CYS Investments Inc. (NYSE: CYS): Shares of CYS Investments Inc. (NYSE: CYS) began the trading session with a price of US$11.97 and throughout the session made a new 52-week low of US$11.45. When day-trade ended, the stock finally plunged 3.55% to US$11.67. CYS traded 10.06 million shares in the last trading session, well above its daily average of 3.64 million shares. Are CYS Investments insiders starting to take huge profits by selling shares or exercising stock options? Add CYS into your watch list for insider trade now.

Read Full Report: http://www.Pennystocksinsiders.com/PR/111512A/CYS/CYSInvestments.pdf

Today Pennystocksinsiders.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.

Prospect Capital Corporation (NASDAQ: PSEC):

Read Full Report: http://www.Pennystocksinsiders.com/PR/111512A/PSEC/ProspectCapital.pdf

Huntington Bancshares Incorporated (NASDAQ: HBAN):

Read Full Report: http://www.Pennystocksinsiders.com/PR/111512A/HBAN/HuntingtonBancshares.pdf

Nektar Therapeutics (NASDAQ: NKTR):

Read Full Report: http://www.Pennystocksinsiders.com/PR/111512A/NKTR/NektarTherapeutics.pdf

Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.

About Pennystocksinsiders.com:

Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.

Important Disclaimer:
Please visit Pennystocksinsiders.com/disclaimers/index.php for details.

SOURCE Pennystocksinsiders.com



RELATED LINKS
http://www.pennystocksinsiders.com/index.php
http://www.pennystocksinsiders.com/disclaimers/index.php
http://www.pennystocksinsiders.com/mediaroom/1214/

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.